Apogee Therapeutics, Inc. 3 SEC Filings

Filed On	Filing
30 May 2024	Form 3: Bollinger Lisa, Director No securities owned
21 Aug 2023	Form 3: McKenna Mark C., Director No securities owned
13 Jul 2023	Form 3: Dambkowski Carl, Chief Medical Officer Holds 279,105 shares of Common Stock
13 Jul 2023	Form 3: Henderson Jane, Chief Financial Officer Holds 188,286 shares of Common Stock
13 Jul 2023	Form 3: Henderson Michael Thomas, Director Holds 1,404,304 shares of Common Stock
13 Jul 2023	Form 3: Fox Jennifer A., Director Holds 30,187 shares of Common Stock
13 Jul 2023	Form 3: Jones William A Jr, Director Holds 30,187 shares of Common Stock
13 Jul 2023	Form 3: Gottesdiener Andrew, Director No securities owned
13 Jul 2023	Form 3: Shah Nimish P, Director
13 Jul 2023	Form 3: Fairmount Funds Management Llc, Director and 2 others

Comments